Immediate Impact
3 from Science/Nature 58 standout
Citing Papers
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
2022 Standout
Works of C. Tournigand being referenced
Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study
2012
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| C. Tournigand | 481 | 211 | 119 | 35 | 598 | |
| Joseph Sgouros | 340 | 115 | 80 | 33 | 704 | |
| Clemens Gießen-Jung | 506 | 203 | 114 | 33 | 678 | |
| Rossana Casaretti | 522 | 205 | 73 | 44 | 649 | |
| D. Braumann | 328 | 161 | 168 | 28 | 556 | |
| P Dufour | 380 | 107 | 59 | 23 | 519 | |
| Alexandre A. Jácome | 301 | 172 | 30 | 42 | 542 | |
| Tzu‐Chen Lin | 433 | 159 | 79 | 30 | 664 | |
| Alberto F. Sobrero | 554 | 217 | 90 | 66 | 671 | |
| Chee Kian Tham | 249 | 139 | 70 | 40 | 641 | |
| Mengyang Di | 284 | 123 | 68 | 42 | 720 |
All Works
Loading papers...